Company intelligence / Profile preview

Arnasi

Woburn, Massachusetts, United Statesarnasigroup.com ↗

Ownership: Private
Development stage: Commercial

Overview

Arnasi has developed a patented liquid-infused surface technology designed to prevent biofilm formation and bacterial infections on implantable medical devices such as catheters and joint replacements. The company is applying this platform to address unmet needs in infection control for high-risk patient populations. Clinical results have not been published; the focus is currently on product development and early adoption

Therapeutic areas: Infectious Diseases
Modalities: DeviceCoating technology (liquid-infused surfaces)
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Arnasi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arnasi.

Explore the full profile